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(C. Kerkhoff).Viral double-stranded RNA (dsRNA) and its synthetic analog polyI:C are recognized via multiple
pathways and induce the expression of genes related to inﬂammation. In the present study, we dem-
onstrated the polyI:C-induced gene expression of the damage associated molecular pattern (DAMP)
molecules S100A8 and S100A9, while other S100 genes were not affected. Cycloheximide and Brefel-
din A treatment revealed both the expression of S100A8 and S100A9 as secondary response genes
and the involvement of polyI:C-induced cytokines herein. Several type I and type III interferons such
as IFNb, IL-20, IL-24, and IFNk/IL-29 were expressed in response to polyI:C, however, they failed to
induce S100A8 and S100A9 gene expression. These data indicate the involvement of the danger mol-
ecule S100A8/A9 in the resistance against viruses.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Human skin is continuously exposed to various pathogens of
prokaryotic, eukaryotic, and viral origin. Emerging evidence sug-
gests that in addition to their essential contribution in forming a
physical barrier, epidermal keratinocytes play an important role
in innate immune mechanisms against skin infections. They are
equipped with a set of pathogen recognition receptors (PRRs) and
antimicrobial proteins enabling them to mount an efﬁcient and
sustained immune response. Some of the innate immune effector
molecules, including lysozyme, secretory leukoprotease inhibitor
or antileukoprotease, RNase 7 and dermcidin 4, are constitutively
produced by healthy skin keratinocytes. Other antimicrobial
peptides such as members of the S100 protein family are locallychemical Societies. Published by E
eximide; CHL, chloroquine;
, double-stranded RNA; HSV,
eptors; VZV, varicella-zoster
tracorporeal Immunmodula-
Fax: +49 3212 2701962.
laus.kerkhoff@uni-rostock.deinduced in skin keratinocytes after infection or inﬂammation. For
example, their expression is induced either directly by microbial
ligands binding to Toll-like receptors (TLRs) [1] or indirectly by
proinﬂammatory cytokines that are released from activated mac-
rophages/phagocytes [2–4].
The members of the S100 protein family comprise a multi-
genic group of non-ubiquitous cytoplasmic Ca2+-binding proteins
of the EF-hand type that are differentially expressed in a wide
variety of cell types. They are small acidic proteins (10–12 kDa)
that are found exclusively in vertebrates [5], and have been impli-
cated in the regulation of many diverse processes such as signal
transduction, cell-cycle regulation, differentiation, and cell sur-
vival [6,7].
S100A8 and S100A9 are twomembers of the S100 protein family
that exert antimicrobial and chemotactic properties [8,9], suggest-
ing their involvement in defense against microorganisms and/or in
chemo attraction of inﬂammatory cells. It has been assumed that
their antimicrobial activity depends on the binding of zinc [10] as
well as other bivalent cations such as Mn2+ [11]. Interestingly, pso-
riasis patients have enhanced levels of S100A8 and S100A9 com-
pared to atopic dermatitis patients [12] and do not suffer from
secondary infections. Moreover, the S100A8 and S100A9 genelsevier B.V. All rights reserved.
A. Voss et al. / FEBS Letters 586 (2012) 196–203 197expression is identiﬁed as an early event in the development of the
psoriasis phenotype of JunB/c-Jun double-mutant mice, well before
any histological alterations or deregulation of other cytokines is ob-
served [13].
S100A8 and S100A9 are predominately expressed in cells of the
myeloid lineage. Beside their constitutive expression in myeloid
cells, they are expressed in epithelial cells in response to stress
[14,15]. Their expression is transiently induced in keratinocytes
after epidermal injury [16,17], after UVB irradiation [18], and in re-
sponse to proinﬂammatory cytokines such as TNFa and IL1b [14].
Data showing that the two S100 proteins are up regulated by the
putative TLR ligand LPS are conﬂicting [19,20].
However, there are no data concerning gene expression of
S100A8 and S100A9 in response to virus infection. Therefore,
we investigated the gene expression of a number of S100 pro-
teins in keratinocytes using the TLR3 speciﬁc ligand polyI:C that
represents a synthetic analog of viral double-stranded RNA
(dsRNA). We found that S100A8 and S100A9 are speciﬁcally up-
regulated in response to polyI:C. Detailed analysis revealed that
S100A8 and S100A9 were induced as secondary response genes,
and their induction was not dependent on type I and type III
interferons. Further analysis gives evidence for epithelial cell-
type speciﬁc anti-viral response and distinct underlying molecu-
lar mechanisms.
2. Materials and methods
2.1. Cell culture
HaCaT (human keratinocyte cell line) cells were cultured in Dul-
becco’s modiﬁed Eagle’s medium (Biochrom AG, Germany) con-
taining 10% heat-inactivated fetal bovine serum (Biowest,
France), 100 units of penicillin (Biochrom AG, Germany) and
2 mM L-glutamine (Biochrom AG, Germany) at 37 C in a humidi-
ﬁed atmosphere with 5% CO2. The Ethical Committee of the Univer-
sity Hospital, Muenster, Germany, approved all described studies.
The study was conducted according to the Declaration of Helsinki
Principles.
2.2. Quantitative PCR
HaCaT cells were stimulated as indicated. Total RNA was ex-
tracted using an RNA Isolation Kit (Macherey & Nagel, Germany)
and ﬁrst strand cDNA was synthesized according to common
molecular biological techniques. The mRNA levels of genes of inter-
est were estimated by real-time PCR using speciﬁc primers. The
primers used are listed in Table S1. The CT values of genes of interest
were normalized to GAPDH. Gene expression is given in relation to
the corresponding gene expression in non-stimulated cells: DCT
Gene (polyI:C)  DCT Gene (non-stimulated) =DDCT Gene (pol-
yI:C). In some cases, gene expression is shown as 15-DCT values.
This presentation was used to show that high DCT values represent
high expression of the target RNA. One cycle difference between
two target genes (15-DCT value of one target – 15-DCT value of
another target) indicates a 2n-fold difference of speciﬁc mRNA be-
tween these targets.
2.3. HSV-1 infection model
Before infecting the organotypic skin models (Phenion) an epi-
dermal lesion was stimulated by scratching them superﬁcially with
a cannula. Each scratch was infected with 2  104 PFU HSV-1 strain
17 syn+ and after incubation of 24 h skin models were ﬁxed in 4%
buffered formalin and parafﬁn-embedded. Sections of tissue wereprepared for immunohistochemistry by clearing with xylene
(5 min) and rehydrating through a graded series of ethanol solu-
tions (96–50%). To reduce non-speciﬁc binding of antibodies the
slides were incubated with 2% BSA/PBS for 20 min. Then the sec-
tions were incubated with mouse anti-HSV-1 serum for 1 h and
subsequently washed with 2% BSA/PBS. S100A9 was labeled with
rabbit anti-human-S100A9 under the same conditions as HSV-1
and subsequently washed with 2% BSA/PBS. As second biotinylated
antibodys Goat anti Mouse IgG FITC for HSV-1 serum staining and
Goat anti Rabbit IgG Texas Red for rabbit anti-S100A9 staining
were used in combination with DAPI, respectively. Finally, cells
were washed with 2% BSA/PBS and analyzed using a ﬂuorescence
microscope. (Axioskop HBO50, Zeiss).
2.4. Data analysis
Data from measurements are given as means ± S.E.M. Statistical
signiﬁcance of differences between means was established by Stu-
dent’s t-test, and probability values of p < 0.05 were considered to
represent signiﬁcant differences.
3. Results and discussion
3.1. S100A8 and S100A9 are speciﬁcally up regulated
in response to polyI:C
In order to investigate the gene expression of various S100 pro-
teins expressed in epithelial cells in response to TLR3 ligation, Ha-
CaT keratinocytes were treated with 50 lg/ml polyI:C, a synthetic
analog of viral double-stranded RNA (dsRNA), for 12 h followed
by real-time PCR (Fig. 1).
As shown in Fig. 1a and b, the expression of S100A8 and S100A9
genes is induced by polyI:C. After 12 h, S100A8 and S100A9 gene
expression was n3.7 = 13.0 and n3.6 = 12.1-fold increased in HaCaT
keratinocytes treated with 50 lg/ml polyI:C, respectively. Their
expression at the protein level was conﬁrmed by ﬂuorescence
immunocytochemical analysis (Fig. S1). In contrast, the gene
expression of neither S100A7, S100A12, S100A15L, nor S100A15S
was signiﬁcantly affected by polyI:C treatment, indicating that
S100A8 and S100A9 are speciﬁcally up regulated upon TLR3 liga-
tion. Poly(U:A) failed to increase the expression of the indicated
genes, demonstrating that the effect was speciﬁc for polyI:C (data
not shown).
Varying the concentration of polyI:C in the range of 0 to 100 lg/
ml as well as the incubation time, we found that polyI:C induced
the expression of S100A8 and S100A9 in a dose- and time-depen-
dent manner. After 16 h, S100A8 and S100A9 gene expression was
n3.1 = 8.6 and n3.9 = 14.9-fold increased in HaCaT keratinocytes
treated with 50 lg/ml polyI:C, respectively (Fig. 1c and d). Maxi-
mal mRNA transcript level for S100A8 and S100A9 was achieved
at 50 lg/ml polyI:C and after 12 h followed by a slight decline
(Fig. 1e and f).
There are some reports showing that TLR2/4 ligand LPS in-
duces S100A8 (and S100A9) gene expression in myeloid cells
[21], however, LPS failed to induce S100 gene expression in
keratinocytes (data not shown) and ﬁbroblasts [22]. On the other
hand, it has been reported that the gene expression of S100A7
and S100A15 is induced in response to TLR5 ligand ﬂagellin
[23,24]. Together these data might indicate that S100 gene
expression is induced in a TLR subtype-speciﬁc manner. Thus, it
is conceivable that TLR subtype-speciﬁc S100 gene expression
might play a key role in determining the type of subsequent
cutaneous immune response generated against a particular
pathogen.
Fig. 1. Effect of polyI:C on the expression of various S100 genes, IL-8 and MCP-1. (a, b) Comparison of the activation of HaCaT keratinocytes induced by polyI:C. HaCaT cells
were stimulated for 12 h with 50 lg/ml polyI:C. Total RNA was then extracted from the cells, and S100 gene expression analysis was performed as described in Materials and
Methods. (a) CT values of S100 genes were normalized to GAPDH and ﬁnal data are shown as 15-DCT values. The number of experiments was n = 3. (b) S100 gene expression is
also given in relation to the corresponding S100 gene expression in non-stimulated cells: DCT S100 (polyI:C)  DCT S100 (non-stimulated) = DDCT S100 (polyI:C) and shown
as 2DDCt. The number of experiments was n = 3, and the asterisks indicate statistically signiﬁcant differences. (c-f) Concentration (c-d) and time (e-f) -dependent effects of
polyI:C on the gene expression of S100A8 (c, e) and S100A9 (d, f). HaCaT cells were stimulated for 12 h with a series of concentrations of polyI:C (10, 30, 40, 50, and 100 lg/ml;
c–f) or with 50 lg/ml polyI:C for various times (2, 4, 8, 12, 16, 20, and 24; g–k). CT values of genes were normalized to GAPDH and ﬁnal data are shown as 15-DCT values. The
number of experiments was n = 3.
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epidermal keratinocytes
Organotypic epithelial ‘‘raft’’ cultures have been used for the
study of herpes simplex virus (HSV) infection [25], and HSV-1 is
a double-stranded DNA virus with double-stranded RNA (dsRNA)
intermediates [26]. Therefore, organotypic cultures of human fore-
skin keratinocytes were scratched, infected with HSV-1 for 24 h,
and analyzed for S100A9 gene expression. S100A9 was stained
with a S100A9-specifc polyclonal antibody (red ﬂuorescence),
and HSV-1 antigens were detected by an anti-HSV-1 sera (green
ﬂuoresence). DAPI (4,60-diamidino-2-phenylindole), a blue ﬂuores-
cent dye, was used for staining nuclei (double-stranded DNA)
(Fig. 2).
Histological examination of the culture sections showed that
infection of the rafts with HSV-1 produced cytopathic effects,
resulting in ballooning and reticular degeneration of the keratino-
cytes together with the occurrence of intranuclear eosinophilic
inclusion bodies, formation of typical intraepithelial vesicles, and
multinucleation.
HSV-1 staining (green signal) revealed that the infection was
not limited to a speciﬁc layer of the differentiated epithelium,
and the infection appeared to spread (Fig. 2b). Strong S100A9 ﬂuo-
rescence (red signal) was found to be localized at the membranes
of HSV-1-infected epidermal keratinocytes (Fig. 2a). Membrane-
associated S100A9 has been described for epithelial cells in spe-
ciﬁc conditions, and it has been suggested that membrane-associ-
ated S100A8/A9 confers resistance to infection [27,28]. In controlexperiments, S100A9 expression was not detected after scratching
in the corresponding organotypic model if the HSV-1 infection was
omitted (data not shown). These data conﬁrm that epidermal
keratinocytes produce S100A8 and S100A9 in response to viral
infection.
3.3. PolyI:C-induces S100 gene expression as secondary
response genes by secreted cytokines
In the course of our expression analysis, we found that several
genes were induced until 2 h while the expression of the S100
and other genes were induced from 4 to 12 h. Some have been re-
ferred to as secondary response gene deﬁned by their upregulation
by a primary stimulus but their expression is blocked in the pres-
ence of cycloheximide [29]. Therefore, we investigated the polyI:C-
induced S100 gene expression in the presence of 1 and 5 lg/ml
cycloheximide (CHX). CHX treatment markedly inhibited in a con-
centration-dependent manner the polyI:C-mediated expression of
mRNA for S100A8 (Fig. 3a) and S100A9 (Fig. 3b). Semiquantitative
analysis showed that 5 lg/ml of CHX completely inhibited S100
gene expression in HaCaT keratinocytes. The expression level of
other genes such as IL-8, MCP-1, IFNb, IL-29, was unaltered (data
not shown), indicating that their induction is the direct result of
primary signal transduction and did not require new protein syn-
thesis. Theses data suggest that S100 genes are secondarily acti-
vated by a primary response gene.
To answer the question wether gene induction was mediated by
secreted cytokines, the fungal metabolite Brefeldin A was tested.
Fig. 2. Immunohistochemical analysis of S100A9 in organotypic epithelial raft cultures of HSV-1 lesions. Organotypic cultures of human foreskin keratinocytes were
scratched and infected with HSV-1 for 24 h followed by immunohistochemically staining with goat anti-S100A9 and anti-HSV-1 sera. After staining, the sections were
counterstained with DAPI. Magniﬁcations 5 and 10. (a) anti-S100A9 (red ﬂuoresence), (b) anti-HSV-1 serum (green ﬂuoresence), (c) merge.
Fig. 3. Effect of CHX (a, b) and Brefeldin A (c, d) upon polyI:C-induced S100 gene expression in HaCaT keratinocytes. (a, b) Cells were stimulated with synthetic dsRNA polyI:C
(50 lg/ml) for 24 h with or without preincubation with indicated concentrations of CHX and subjected to real-time PCR. (c, d) Cells were stimulated with synthetic dsRNA
polyI:C (50 lg/ml) for 24 h with or without preincubation with 50 ng/ml Brefeldin A and subjected to real-time PCR. S100 gene expression is given in relation to the
corresponding S100 gene expression in non-stimulated cells: DCT S100 (stimulated)  DCT S100 (non-stimulated) =DDCT S100 (stimulated) and shown as 2DDCt. The
number of experiments was n = 3. The data is presented as the mean ± SEM of three independent experiments.
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plasmic reticulum to the Golgi apparatus [30], and leads to the rapid
accumulation of proteins within the ER and collapse of the Golgi
stacks [31]. As shown in Fig. 3c and d, Brefeldin A strongly inhibitedpolyI:C-mediated S100 gene expression. Similar was found for
MMP-9 and MCP-1 (data not shown). These data indicate the
involvement of secreted cytokines that were expressed in response
to polyI:C.
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Very recently, it has been shown that IL-10 is involved in
S100A8 gene induction by dsRNA in monocyte/macrophages [32].
Conversely, we failed to detect IL-10 mRNA transcripts in HaCaT
keratinocytes after polyI:C treatment (data not shown). Our data
are consistent with other reports [33,34]. IL-10 appears to be
mainly produced by skin-inﬁltrating activated T cells in Th2
pathologies such as atopic dermatitis, melanoma and lymphomas,
whereas a relative deﬁciency is found in psoriasis, a Th1 disease
[22]. Thus, the underlying molecular mechanisms of S100A8 and
S100A9 gene expression in response to TLR3 ligation appears to
be cell-type speciﬁc.
Time-dependent expression analysis of S100A8, S100A9, and
other secondary response genes such as MxA and ISG-20 point to
the S100 induction by cytokines that are released from keratino-
cytes upon polyI:C stimulation. In order to identify this cytokineFig. 4. Gene expression of IFNa (a), IFNb (b), IFNc (c), IFNk/IL-29 (d), IL-19 (e), Il-20 (f)
stimulated with 50 lg/ml polyI:C for different time intervals as indicated. Total RNA w
described in Materials and Methods. CT values of genes were normalized to GAPDH andwe analyzed the time-dependent expression of IFNa, IFNb, and
IFNc as well as several novel interleukin-10-related cytokines such
as IL-19, IL-20, IL-24, and IL-26, and IL-29/IFNk [35].
As shown in Fig. 4b and d, polyI:C treatment induces a rapid
but transient IFNb and IFNk/IL-29 generation in HaCaT keratino-
cytes. Maximal IFNb and IFNk/IL-29 mRNA transcript levels were
measured after 4 h followed by a slight decline. In contrast, the
gene expression of IFNa and IFNc was not affected (Fig. 4a
and c).
IL-19 and IL-26 mRNA transcripts were detected at low levels in
HaCaT keratinocytes, and their levels were not modulated by pol-
yI:C treatment (Fig. 4e and h). The level of IL-20 mRNA transcripts
was slightly increased in response to polyI:C whereas IL-24 gene
expression was continuously increased (Fig. 4f and g). With respect
to the time kinetics IFNb, and IFNk/IL-29 appear as suitable candi-
dates being responsible for the polyI:C-induced S100A8 and
S100A9 gene expression., IL-24 (g), and IL-26 (h) in polyI:C-treated HaCaT keratinocytes. HaCaT cells were
as then extracted from the cells, and gene expression analysis was performed as
ﬁnal data are shown as 15-DCT values. The number of experiments was n = 3.
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and b). In control experiments, IFNb induced the expression of
MxA (data not shown) and ISG-20 (Fig. 5c). Interestingly, both
genes were induced more potently by polyI:C than IFNb. Notably,
IFNb is well-known to induce the expression of a number of genes
by activating Jak-Stat, p38 MAPK, PI3K, IKKs, and NFjB [36], and
consistent with this report, we observed an inhibitory effect of cor-
responding inhibitors upon polyI:C-induced S100 gene expression
(Fig. S2). However, our data clearly indicate that S100 induction
did not depend on IFNb stimulation.
IFNk/IL-29 shares with type I interferon the same Jak/Stat sig-
nalling pathway driving expression of a common set of genes
although IFNk/IL-29 binds to a distinct membrane receptor [37].
However, similar to IFNb, IFNk failed to induce S100 gene expres-
sion (Fig. 5d and e). It has been reported that the combination of
both synergistically increases gene expression, however, we did
not observe any synergistic up-regulation of the two S100 genes
(data not shown). Interestingly, both MxA (data not shown) and
ISG-20 (Fig. 5f) were induced more potently by polyI:C than IFNb
or the combination of IFNb and IL-29. In addition, we did not ob-
serve an auto regulatory loop for either IFNb or IFNk/IL-29 to in-
duce themselves (data not shown).
Keratinocytes play an important role in inﬂammatory and im-
mune reactions [38,39], and dsRNA elicits a variety of responses in-
duced by viral infection in epithelial cells [40]. In the present study,
dsRNA was demonstrated to induce S100A8 and S100A9 gene
expression in HaCaT keratinocytes; indicating that they might be
involved in antiviral resistance against viruses. Interestingly, other
antimicrobial proteins such as Galectin-9 [41], b-defensin-1, -2
[42,43] and -3 [43,44] were also found to be induced by TLR3Fig. 5. Gene expression of S100A8 (a, d), S100A9 (b, e), and ISG-20 (c, f) in HaCaT keratin
with IFNb or IFNk for different time intervals as indicated. Total RNA was then extracted f
and Methods. CT values of genes were normalized to GAPDH and ﬁnal data are shown aagonists. Although the underlying molecular mechanisms remain
unclear, the co-expression of antimicrobial proteins with
proinﬂammatory cytokines and chemokines point to an important
role in antiviral innate immunity. Moreover, it has been shown that
antimicrobial peptides augment TLR-mediated responses [45],
thereby probably mediating a more stringent host defence
response.
Recently, Sorci et al. [46] presented a novel concept in which
the danger molecule S100B integrates pathogen- and danger-
sensing pathways to restrain inﬂammation in Aspergillus fumiga-
tus infection. Extracellular S100B binds to RAGE, induces its
association with TLR2 and results in TLR2 inhibition. However,
intracellular S100B binds nucleic acids, activates an TLR3/TLR9/
TRIF-dependent pathway, leading to the transcriptional down-
regulation of S100B. By this spatiotemporal integration of signals
from TLRs and RAGE the danger signal S100B protects the host
against pathogen-induced inﬂammation and a nucleic acid-sens-
ing mechanism resolves danger-induced chronic inﬂammation.
S100A8 and S100A9 are also included in the group of proteins
termed damage associated molecular pattern (DAMP) molecules.
In epithelial cells, intracellular S100A8/A9 exerts a growth-inhibi-
tory effect after its stress response-induced expression [47]. How-
ever, after its secretion, S100A8/A9 binds to both RAGE [48] and
TLR4 [49]. TLR4 is linked with innate immunity that programs local
inﬂammation, and RAGE mediates post-receptor signaling includ-
ing activation of NF-jB, leading to a profound inﬂammatory re-
sponse. In view of these ﬁndings further investigations are
required to explore whether the danger signal S100A8/A9 can
modulate pathogen- and danger-sensing pathways to regulate im-
mune homeostasis in health and disease.ocytes after stimulation with IFNb (a–c) or IFNj (d–f). HaCaT cells were stimulated
rom the cells, and gene expression analysis was performed as described in Materials
s 15-DCT values. The number of experiments was n = 3.
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